CORDIS Project
Funding breakdown and partner intelligence are Premium
Sign in and upgrade to Premium for EU contribution totals, consortium analytics, OpenAlex research context, and AI summaries. · 0 consortium intelligence fields visible of 1
Start free • Cancel anytime • 14-day refund guarantee
This project aims to improve gene therapy for cardiovascular diseases by developing novel adeno-associated virus serotypes that can evade immune responses. The goal is to create effective vectors for targeted treatment and personalized medicine.
Cardiovascular diseases remain the primary cause of morbidity and mortality in the western countries.
Pharmacological treatment improves survival and quality of life, but does not reverse disease progression.
Gene therapy could fill this void, owing to its ability to treat the underlying cause.
Adeno-associated viruses (AAV) emanated in the past decade as potent vectors, owing to their tropism for specific tissues, their low immunogenicity, their lack of pathogenicity and their ability to sustai…
UNIVERSITATSKLINIKUM HEIDELBERG
Partner organizations (coordinator is shown above), with normalized type and CORDIS activity type. Guests see up to 4 partners.
Similar projects, consortium collaboration history, frequent partners, and OpenAlex research context.
Guests see up to 5 EuroSciVoc fields.
Guests see up to 5 topics.
